Target intelligence / Profile preview

Cutaneous T cell (null)

Target
null
Molecular classification
Other (T cells are a type of immune cell, not a single molecular target or receptor), Lymphocyte, Immune cell subtype
01

Overview

"Cutaneous T cells" refers broadly to **T lymphocytes that reside within the skin**. These are immune system white blood cells specialized for surveillance and defense against pathogens at the skin barrier. They include both **CD4+ helper** and **CD8+ cytotoxic** subtypes, among others. Cutaneous T cells play key roles in recognizing antigens presented by local antigen-presenting cells via their unique **T-cell receptors**, leading to activation and orchestration of local immune responses[1][2][3]. They contribute to protection from infection but can also be involved in inflammatory diseases and certain cancers such as cutaneous T-cell lymphoma.\n\nNote on correctness: "Cutaneous T cell" is *not* the name of a molecule or receptor but rather describes a population/subset of immune cells based on tissue localization. It is therefore incorrect as an entry for a molecular drug target; more precise targets would be individual molecules expressed by these cells (e.g., CD4, CD8, CCR4) or their receptors such as the "T-cell receptor"[2][4].

Other names
Skin T cellskin-resident T cellcutaneous lymphocyte (non-standard)
02

Biological functions

Immune responsePathogen recognition and eliminationCytokine productionRegulation of inflammationSurveillance against infection and cancer
03

Disease associations

Cancer (cutaneous T-cell lymphoma)Infection (skin infections)Inflammation (autoimmune skin diseases such as psoriasis or dermatitis)

Beyond the preview

Go deeper on Cutaneous T cell (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cutaneous T cell (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call